Tag: Allergan
US: Duke, Allergan beat antitrust suit
According to Bloomberg, Duke University and Allergan convinced a District of New Jersey judge to strip antitrust counterclaims from their lawsuit accusing Akorn of...
US: Allergan to shed two drugs for AbbVie deal
Allergan has confirmed that it will divest experimental inflammatory bowel disease therapy brazikumab and marketed drug Zenpep ahead of its US$63 billion acquisition by...
US: Allergan beats Class Certification appeal
The union pension funds claiming Allergan delayed the rollout of generic Asacol will have to wait until the end of trial-level proceedings to challenge...
US: AbbVie to Buy Allergan for $63B
US drugmaker AbbVie has agreed to buy Allergan, the Irish-domiciled maker of Botox, in a US$63 billion that is the sector’s latest blockbuster transaction...
US: Allergan safe from new class certification bid in antitrust case
A federal judge on Thursday, April 11, declined to consider a request to certify a class of health plans and insurers who claim the...
US: Shire sues Allergan for hindering competition
Shire filed an antitrust suit against Allergan, alleging Allergan's contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access...
